• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

acne

Ycanth: First Treatment for Molluscum Contagiosum and Warts
Posted inClinical Trials, Infections

Ycanth: First Treatment for Molluscum Contagiosum and Warts

May 25, 2022September 8, 2022

Cantharidin Verrica Pharmaceuticals can help get rid of common viral skin lesions.

Aklief, Amzeeq, Winlevi: Newest Drugs for Acne Vulgaris Treatment
Posted inInfections, New Drugs, Regulatory

Aklief, Amzeeq, Winlevi: Newest Drugs for Acne Vulgaris Treatment

December 11, 2021November 5, 2022

Trifarotene, minocycline, and clascoterone are new effective drugs for the topical treatment of acne in children and adults.

Sanofi to Make Vaccine Against Acne
Posted inInfections, Pharma & Biotech

Sanofi to Make Vaccine Against Acne

December 2, 2021September 8, 2022

Acne vulgaris treatment will reach a new level of quality.

BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2023 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News